Sanara MedTech grants stock to controller Mackey

Mackey Ashley M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Mackey Ashley M reported acquisition or exercise transactions in this Form 4 filing.

Sanara MedTech Inc. reported that Controller Ashley M. Mackey received a grant of 2,804 shares of common stock as equity compensation. The shares were awarded at no cash cost and increased her direct holdings to 5,067 shares after the transaction.

According to the filing, the 2,804 granted shares are restricted stock issued under the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. They will vest in three equal installments on March 22, 2027, March 22, 2028 and March 22, 2029, provided she remains employed with the company through each vesting date.

Insider Trade Summary

Grant/Award: 2,804 shares

Grant/Award 1 txn

Insider Mackey Ashley M

Role Controller

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,804	$0.00	$0.00

Holdings After Transaction: Common Stock — 5,067 shares (Direct)

Footnotes (1)

1. F1. Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sanara MedTech (SMTI) report on this Form 4?

Sanara MedTech reported a grant of 2,804 shares of common stock to Controller Ashley M. Mackey. The award is equity compensation, not an open-market purchase or sale, and was issued at no cash cost, increasing her direct holdings to 5,067 shares.

Who is the insider named in the Sanara MedTech (SMTI) Form 4 filing?

The insider is Ashley M. Mackey, who serves as Controller at Sanara MedTech Inc. The filing shows she received a restricted stock grant of 2,804 common shares, bringing her direct ownership position to 5,067 shares after the reported transaction.

How many Sanara MedTech (SMTI) shares did the insider receive and now hold?

Ashley M. Mackey received 2,804 shares of restricted common stock as a grant. After this award, her total direct holdings increased to 5,067 shares of Sanara MedTech common stock, according to the ownership figures disclosed in the Form 4 filing.

What are the vesting terms of the Sanara MedTech (SMTI) restricted stock grant?

The 2,804 restricted shares will vest in three equal installments over time. One-third vests on March 22, 2027, another third on March 22, 2028, and the final third on March 22, 2029, if Ashley M. Mackey remains employed through each date.

Under which plan was the Sanara MedTech (SMTI) restricted stock granted?

The restricted stock was granted under the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. This plan allows the company to issue equity awards, such as restricted stock, to employees like Controller Ashley M. Mackey as part of long-term compensation.

Was the Sanara MedTech (SMTI) Form 4 transaction a market purchase or sale?

No, the transaction was not a market purchase or sale. It reflects a grant of 2,804 shares of restricted common stock to Controller Ashley M. Mackey as compensation, with no purchase price per share, and a multi-year vesting schedule tied to continued employment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 04:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mackey Ashley M

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TEXAS 76102

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Controller

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/22/2026		A		2,804(1)	D	$0(1)	5,067	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.

	/s/ Ashley M. Mackey	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)